Prof. Milena Georgieva, Epix AI co-founder, speaks on epigenetics and longevity in China
At the Geneva College of Longevity Science symposium in Guangzhou, our CSO explained how epigenetics and AI are changing longevity science.
Prof. Milena Georgieva, co-founder and Chief Scientific Officer of Epix AI, travelled to China to speak about how epigenetics and AI are reshaping longevity science through personalised health strategies.
The Geneva College of Longevity Science Semester Symposium, held in Guangzhou, brought together international experts and innovators for two days focused on human longevity.
Prof. Georgieva gave a plenary lecture on epigenetics and AI that sparked a lively discussion. She argued that combining the two can help extend healthy lifespan and lower the risk of age-related disease, with personalisation at the centre of the approach.
“By tailoring interventions to each person’s unique biological profile, we can move beyond one-size-fits-all healthcare.”
Her talk highlighted data-driven personalised medicine, the area where Epix AI is building its Dynamic Health Score platform and proprietary biological age clocks.
The symposium showed how much interdisciplinary collaboration matters in the science of aging. For Epix AI, taking part reflects our goal of pairing scientific rigour with innovation, so that people live better, not just longer.